KK
SANA icon

KLP Kapitalforvaltning’s Sana Biotechnology SANA Stock Holding History

KLP Kapitalforvaltning’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126K Hold
36,200
– – ﹤0.01% 2037
2026
Q1 		$104K Hold
36,200
– – ﹤0.01% 2043
2025
Q4 		$147K Buy
36,200
+8,000
+28% +$35.8K ﹤0.01% 1948
2025
Q3 		$100K Buy
+28,200
New +$102K ﹤0.01% 2065
2025
Q2 		– Sell
-24,200
Closed -$40.7K – 2256
2025
Q1 		$40.7K Hold
24,200
– – ﹤0.01% 2211
2024
Q4 		$39.4K Buy
+24,200
New +$72.2K ﹤0.01% 2262

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

KLP Kapitalforvaltning's SANA Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Sana Biotechnology (SANA) position steady in Q2 2026 at 36,200 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #2037.

KLP Kapitalforvaltning first reported a position in SANA in Q4 2024 and has held it in 6 quarters since. The position peaked at $147K in Q4 2025. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • KLP Kapitalforvaltning held 36,200 shares of Sana Biotechnology worth $126K as of Q2 2026.
  • KLP Kapitalforvaltning left its Sana Biotechnology share count unchanged in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #2037 holding.
  • KLP Kapitalforvaltning first reported a position in Sana Biotechnology in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's Sana Biotechnology position peaked at $147K in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.